Market By Cgms Component Type, Cgms End-user, Cgms Demographics, Smbg Type, Smbg End-user And Smbg Application | Forecast 2019-2025
After a detailed analysis, Triton has concluded that the market for continuous glucose monitoring system comprising (CGMS) and self-monitoring of blood glucose (SMBG) in the United Kingdom is expected to upsurge at a CAGR of 33.45% and 5.82% respectively, in the forecast period of 2019 to 2025.
Lucrative reimbursement policies in the United Kingdom are enhancing the adoption rate of blood glucose monitoring devices in the market. As per a survey by Diabetes UK, around 3.7 million people have been diagnosed with diabetes in the country, and 12.3 million people are at an increased risk of Type 2 diabetes. It is estimated that the diabetic population would reach more than 5 million by 2025. The favoring reimbursement policy and the increasing prevalence of diabetes are anticipated to drive the growth in the United Kingdom glucose monitoring system market.
Type 1 patients and insulin-dependent type 2 patients need to measure blood glucose regularly after every meal. Hence, there is a need to develop a technology that overcomes the pain of getting pricked, in order to make the technology more user-friendly. Needlestick injuries are a reality for people who regularly use needles. The global GMS device market is a mature market with the presence of five leading vendors. There is stiff competition among the vendors based on pricing, which lowers their profit margins. Roche Diagnostics and LifeScan have lost more than 3% of their market share over the last three years. These factors are hindering the glucose continuous system market in the United Kingdom.
Triton Market Research’s report on the United Kingdom glucose monitoring system provides in-depth insight and segmentation analysis of the market. The detailed analysis of the market includes: the key buying criteria, PESTEL analysis, value chain analysis, healthcare in the United Kingdom, diabetic care technologies and the market attractiveness index. The segmentation analysis of the United Kingdom glucose monitoring system Market includes: the market by CGMS component type, by CGMS end-user, by CGMS demographics, by SMBG type, by SMBG end-user and by SMBG application.
The noteworthy players in the United Kingdom glucose monitoring system market are Ypsomed Holding AG, Nemaura Medical Inc, B Braun Melsungen AG, Abbott, Becton Dickinson and Company, Medtronic, Dexcom, Ascensia, Roche Diagnostics, Johnson & Johnson, Roche Diagnostics, I-Sens Inc
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. THE UNITED KINGDOM GLUCOSE MONITORING SYSTEM MARKET - SUMMARY
1.2.
MARKET DRIVING ASPECTS
1.3.
MARKET RESTRAINING ASPECTS
1.4. KEY PLAYERS
2. THE
UNITED KINGDOM GLUCOSE MONITORING SYSTEM INDUSTRY OUTLOOK
2.1. MARKET
DEFINITION
2.2. PESTEL
ANALYSIS
2.2.1. POLITICAL
2.2.2. ECONOMICAL
2.2.3. SOCIAL
2.2.4. TECHNOLOGICAL
2.2.5. LEGAL
2.2.6. ENVIRONMENTAL
2.3. HEALTHCARE
IN THE UNITED KINGDOM
2.4. DIABETIC
CARE TECHNOLOGIES
2.5. KEY
BUYING CRITERIA
2.6. VALUE
CHAIN ANALYSIS
2.7. MARKET
ATTRACTIVENESS INDEX
3. THE
UNITED KINGDOM GLUCOSE MONITORING SYSTEM MARKET - SEGMENTATION
3.1. BY CGMS COMPONENT TYPE (SENSORS, TRANSMITTER AND RECEIVERS, INTEGRATED INSULIN PUMPS)
3.2. BY CGMS END USER (HOME SETTINGS, DIAGNOSTICS AND CLINICAL, HOSPITAL)
3.3. BY CGMS DEMOGRAPHICS (ADULT POPULATION (>14YEARS), CHILD POPULATION (>14YEARS))
3.4. BY SMBG TYPE (TEST STRIPS, GLUCOSE METER, LANCETS)
3.5. BY SMBG END USER (HOME SETTINGS, CLINICAL, HOSPITAL)
3.6. BY SMBG APPLICATION (TYPE 1 DIABETES, TYPE 2 DIABETES, GESTATIONAL DIABETES)
4. COMPETITIVE
LANDSCAPE
4.1. ABBOTT
4.2. ASCENSIA
4.3. B
BRAUN MELSUNGEN AG
4.4. BECTON
DICKINSON AND COMPANY
4.5. DEXCOM
4.6. I-SENS,
INC.
4.7. JOHNSON
& JOHNSON
4.8. MEDTRONIC
4.9. NEMAURA
MEDICAL, INC.
4.10.
ROCHE DIAGNOSTICS
4.11.
YPSOMED
5. RESEARCH
METHODOLOGY & SCOPE
5.1. RESEARCH
SCOPE & DELIVERABLES
5.1.1. OBJECTIVES
OF STUDY
5.1.2. SCOPE
OF STUDY
5.2. SOURCES
OF DATA
5.2.1. PRIMARY
DATA SOURCES
5.2.2. SECONDARY
DATA SOURCES
5.3. RESEARCH
METHODOLOGY
5.3.1. EVALUATION
OF PROPOSED MARKET
5.3.2. IDENTIFICATION
OF DATA SOURCES
5.3.3. ASSESSMENT
OF MARKET DETERMINANTS
5.3.4. DATA
COLLECTION
5.3.5. DATA VALIDATION &
ANALYSIS
TABLE
1 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET 2019-2025 ($ MILLION)
TABLE
2 AVERAGE PRICES OF GLUCOSE TEST
STRIPS, LANCETS AND GLUCOSE METER IN THE UNITED KINGDOM (US $)
TABLE
3 THE UNITED KINGDOM - COUNTRY
SNAPSHOT
TABLE
4 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET BY CGMS COMPONENT TYPE 2019-2025 ($ MILLION)
TABLE
5 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET BY CGMS END-USER 2019-2025 ($ MILLION)
TABLE
6 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET BY CGMS DEMOGRAPHICS 2019-2025 ($ MILLION)
TABLE
7 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET BY SMBG TYPE 2019-2025 ($ MILLION)
TABLE
8 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET BY SMBG END-USER 2019-2025 ($ MILLION)
TABLE
9 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET BY SMBG APPLICATION 2019-2025 ($ MILLION)
FIGURE
1 THE UNITED KINGDOM GLUCOSE
MONITORING SYSTEM MARKET 2019-2025 ($ MILLION)
FIGURE
2 THE UNITED KINGDOM SMBG SALES
CHANNEL 2019-2025 ($ MILLION)
FIGURE
3 TECHNOLOGIES IN DIABETIC CARE
FIGURE
4 VALUE CHAIN ANALYSIS OF CGMS MARKET
FIGURE
5 MARKET ATTRACTIVENESS INDEX